Article metrics

Original research
Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial

 

Online download statistics by month:

Online download statistics by month: September 2022 to December 2022

AbstractFullPdf
Sep 2022454468166
Oct 2022368395133
Nov 202216516792
Dec 202212713049
Total11141160440